1. Home
  2. BDSX vs HCAT Comparison

BDSX vs HCAT Comparison

Compare BDSX & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$24.00

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$1.86

Market Cap

129.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
HCAT
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
153.3M
129.4M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
BDSX
HCAT
Price
$24.00
$1.86
Analyst Decision
Strong Buy
Hold
Analyst Count
5
10
Target Price
$32.50
$2.53
AVG Volume (30 Days)
66.3K
856.8K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
$311,136,000.00
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
1.48
52 Week Low
$0.35
$0.96
52 Week High
$25.52
$3.79

Technical Indicators

Market Signals
Indicator
BDSX
HCAT
Relative Strength Index (RSI) 60.37 42.77
Support Level $19.26 $1.61
Resistance Level $24.47 $2.37
Average True Range (ATR) 1.73 0.13
MACD 0.09 -0.05
Stochastic Oscillator 70.61 26.35

Price Performance

Historical Comparison
BDSX
HCAT

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: